CN111419961A - Pain-relieving plaster containing musk and monkshood - Google Patents
Pain-relieving plaster containing musk and monkshood Download PDFInfo
- Publication number
- CN111419961A CN111419961A CN201811567942.2A CN201811567942A CN111419961A CN 111419961 A CN111419961 A CN 111419961A CN 201811567942 A CN201811567942 A CN 201811567942A CN 111419961 A CN111419961 A CN 111419961A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw
- root
- plaster
- monkshood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 60
- 241000173529 Aconitum napellus Species 0.000 title claims abstract description 22
- 241000402754 Erythranthe moschata Species 0.000 title claims abstract description 21
- 208000002193 Pain Diseases 0.000 title claims abstract description 18
- 241000758794 Asarum Species 0.000 claims abstract description 28
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 28
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 28
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 28
- 239000004863 Frankincense Substances 0.000 claims abstract description 28
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 22
- 239000008159 sesame oil Substances 0.000 claims abstract description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 21
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 21
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 17
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 17
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 17
- 239000009136 dragon's blood Substances 0.000 claims abstract description 17
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000123589 Dipsacus Species 0.000 claims abstract description 14
- 241000218671 Ephedra Species 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 241001522129 Pinellia Species 0.000 claims abstract description 14
- 240000002505 Pogostemon cablin Species 0.000 claims abstract description 14
- 235000011751 Pogostemon cablin Nutrition 0.000 claims abstract description 14
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 14
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 230000036407 pain Effects 0.000 claims abstract description 13
- 241000471262 Ardisia japonica Species 0.000 claims abstract description 11
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 10
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 7
- 239000011593 sulfur Substances 0.000 claims abstract description 7
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 7
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 4
- 229940023019 aconite Drugs 0.000 claims abstract 4
- 241000227129 Aconitum Species 0.000 claims description 31
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 19
- 229910052802 copper Inorganic materials 0.000 claims description 19
- 239000010949 copper Substances 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 241001343277 Entada Species 0.000 claims description 10
- 230000009194 climbing Effects 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 241000723347 Cinnamomum Species 0.000 claims description 6
- 241001676573 Minium Species 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000000202 analgesic effect Effects 0.000 claims description 5
- 241001529821 Agastache Species 0.000 claims description 3
- 241000722826 Ardisia Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000000779 smoke Substances 0.000 claims description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 2
- 240000001851 Artemisia dracunculus Species 0.000 claims description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 2
- 239000001138 artemisia absinthium Substances 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 208000008765 Sciatica Diseases 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 4
- 206010047115 Vasculitis Diseases 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 4
- 230000002040 relaxant effect Effects 0.000 abstract description 4
- 208000005801 spondylosis Diseases 0.000 abstract description 4
- 210000002435 tendon Anatomy 0.000 abstract description 4
- 206010005963 Bone formation increased Diseases 0.000 abstract description 3
- 206010056377 Bone tuberculosis Diseases 0.000 abstract description 3
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 abstract description 3
- 206010031252 Osteomyelitis Diseases 0.000 abstract description 3
- 206010031264 Osteonecrosis Diseases 0.000 abstract description 3
- 208000006735 Periostitis Diseases 0.000 abstract description 3
- 208000012287 Prolapse Diseases 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 4
- 206010017577 Gait disturbance Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 208000026137 Soft tissue injury Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000031264 Nerve root compression Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000001819 hydrarthrosis Diseases 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Marine Sciences & Fisheries (AREA)
- Virology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Abstract
The invention belongs to the technical field of plaster, and particularly relates to a musk monkshood pain relieving plaster with a remarkable treatment effect. The plaster comprises the following components: raw kusnezoff monkshood root, raw ephedra herb, raw pinellia tuber, prepared aconite root, raw common monkshood mother root, Japanese ardisia root-bark, liquorice, cinnamon, raw south, cassia twig, pangolin scales, pseudo-ginseng, asarum, teasel root, frankincense, myrrh, sesame oil, dragon's blood, patchouli, salvia miltiorrhiza, folium artemisiae argyi, asarum, hippocampus, musk and sulfur. The plaster has the treatment effects of dispelling wind and clearing heat, relaxing tendons and activating collaterals, relieving swelling and pain, and promoting blood circulation by removing blood stasis. Can be used for treating periostitis, osteomyelitis, bone tuberculosis, aseptic osteonecrosis, hyperosteogeny, vasculitis, sciatica, cervical spondylosis, lumbar vertebra strain, and prolapse of lumbar intervertebral disc. The plaster has no toxic or side effect, is convenient to use, has low production cost, and is suitable for popularization and use in patients with related diseases.
Description
Technical Field
The invention belongs to the technical field of plaster, and particularly relates to a musk monkshood pain relieving plaster with a remarkable treatment effect.
Background
The plaster is one of the external application of traditional Chinese medicines, and is prepared by adding vegetable oil or animal oil and decocting into colloidal substances. The plaster plays a role through skin, follows the principles of traditional Chinese medicine dialectical treatment and traditional Chinese medicine efficacy, main treatment and channel tropism, fully mobilizes the efficacy of the medicines for mutual coordination, and forms a compound of a plurality of medicines so as to play a good effect of the medicines. The plaster has the effects of relaxing tendons, activating collaterals, relieving swelling and pain, promoting blood circulation, removing blood stasis and the like, and is popular with patients with diseases.
With the progress of society, the physical labor intensity is gradually reduced, and people sit and work for a long time to bring a series of diseases, such as vertebral hypertrophy, vasculitis, sciatica, cervical spondylosis, lumbar strain, lumbar disc herniation and other diseases, and are long-term afflicted with the bodies of people. In the prior art, some analgesic plasters appear, but the analgesic plasters cannot be completely cured. Especially for the chronic diseases, no pain-relieving plaster for completely curing the diseases exists.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provide the musk monkshood pain relieving plaster which can radically cure diseases.
The plaster comprises the following components: raw kusnezoff monkshood root, raw ephedra herb, raw pinellia tuber, monkshood, raw monkshood, cortex ardisia, liquorice, cinnamon, raw south, cassia twig, pangolin scales, pseudo-ginseng, asarum, teasel root, frankincense, myrrh, sesame oil, dragon's blood, patchouli, salvia miltiorrhiza, folium artemisiae argyi, asarum, hippocampus, musk and sulfur;
the plaster comprises the following components in percentage by weight: 5-20 parts of raw kusnezoff monkshood root, 10-30 parts of raw ephedra herb, 8-25 parts of raw pinellia tuber, 15-40 parts of monkshood, 6-18 parts of raw monkshood root, 12-36 parts of Japanese ardisia root-bark, 8-15 parts of liquorice, 20-40 parts of cinnamon, 18-26 parts of raw south China, 10-20 parts of cassia twig, 20-50 parts of climbing entada stem, 15-25 parts of pseudo-ginseng, 10-22 parts of asarum, 15-30 parts of teasel root, 25-35 parts of frankincense, 20-30 parts of myrrh, 300-500 parts of sesame oil, 15-30 parts of dragon blood, 5-20 parts of patchouli, 5-12 parts of salvia miltiorrhiza, 18-35 parts of folium artemisiae argyi, 3-8 parts of asarum, 8-22 parts of hippocampus, 6-18 parts of;
the plaster comprises the following components in percentage by weight: 10 parts of raw kusnezoff monkshood root, 11 parts of raw ephedra herb, 16 parts of raw pinellia tuber, 38 parts of prepared common monkshood daughter root, 10 parts of raw common monkshood mother root, 18 parts of Japanese ardisia root-bark, 12 parts of liquorice, 36 parts of cassia bark, 19 parts of raw south China, 14 parts of cassia twig, 37 parts of climbing entada herb, 25 parts of pseudo-ginseng, 18 parts of asarum, 22 parts of teasel root, 35 parts of frankincense, 20 parts of myrrh, 400 parts of sesame oil, 30 parts of dragon's blood, 15 parts of patchouli, 5 parts of salvia miltiorrhiza, 20 parts of folium artemisiae argyi, 8 parts of asarum;
the preparation method of the plaster comprises the following steps,
A. stirring and grinding frankincense and sulfur into powder in a reaction kettle for later use;
B. mixing herba Agastaches, Saviae Miltiorrhizae radix, folium Artemisiae Argyi, herba asari, radix Aconiti Kusnezoffii, Glycyrrhrizae radix, and Hippocampus, and grinding into powder;
C. heating the copper pot, pouring the frankincense and sulfur powder into the copper pot, continuously stirring, pouring the traditional Chinese medicine component powder in the step B into the copper pot after the frankincense powder and the sulfur powder are heated and melted into liquid, and continuously stirring to uniformly melt the traditional Chinese medicine component powder into a whole;
D. then, the musk is put into a copper pot, the copper pot is taken out of the fire, and the musk is cooled to finish the preparation work of the fire-shooting part of the plaster;
E. heating an iron pan, and pouring sesame oil into the iron pan to heat the sesame oil;
F. pouring radix Aconiti Kusnezoffii, herba Ephedrae, rhizoma Pinelliae, radix Aconiti lateralis Preparata, radix Aconiti, cortex Ceratophylli, Glycyrrhrizae radix, cortex Cinnamomi, rhizoma arisaematis, ramulus Cinnamomi, caulis Endadae Phaseoloidis, Notoginseng radix, herba asari, and radix Dipsaci into heated oil pan, stirring to heat the medicine uniformly, heating to liquid, removing residues, filtering, and making into ointment;
G. f, adding frankincense, myrrh and dragon's blood into the cream oil prepared in the step F, and continuously stirring until the mixture is melted;
H. d, pouring the minium into the melted cream oil in the step G, continuously heating, continuously stirring clockwise, stopping heating when the minium emits green smoke, and cooling for later use;
I. and D, adhering the fire-shooting part prepared in the step D with the cream part prepared in the step H to complete the preparation of the plaster.
Preferably, the plaster comprises the following components in proportion: 16 parts of raw kusnezoff monkshood root, 19 parts of raw ephedra, 19 parts of raw pinellia tuber, 35 parts of prepared common monkshood daughter root, 11 parts of raw common monkshood mother root, 28 parts of Japanese ardisia root-bark, 15 parts of liquorice, 40 parts of cassia bark, 20 parts of raw south China, 17 parts of cassia twig, 45 parts of climbing entada herb, 19 parts of pseudo-ginseng, 22 parts of asarum, 28 parts of teasel root, 30 parts of frankincense, 25 parts of myrrh, 409 parts of sesame oil, 17 parts of dragon's blood, 9 parts of patchouli, 11 parts of salvia miltiorrhiza, 30 parts of argy wormwood leaf, 7 parts of asarum, 21.
Preferably, the plaster comprises the following components in proportion: 5 parts of raw kusnezoff monkshood root, 21 parts of raw ephedra herb, 24 parts of raw pinellia tuber, 37 parts of prepared common monkshood daughter root, 10 parts of raw common monkshood mother root, 27 parts of Japanese ardisia root-bark, 14 parts of liquorice, 34 parts of cassia bark, 19 parts of raw south China, 13 parts of cassia twig, 41 parts of climbing entada herb, 20 parts of pseudo-ginseng, 22 parts of asarum, 26 parts of teasel root, 31 parts of frankincense, 24 parts of myrrh, 450 parts of sesame oil, 19 parts of dragon's blood, 16 parts of patchouli, 11 parts of salvia miltiorrhiza, 30 parts of folium artemisiae argyi, 8 parts of asarum.
In the step C of the preparation method of the plaster, the temperature of a copper pot is heated to 80-110 ℃, and then the frankincense and sulfur powder are poured into the copper pot and are continuously stirred.
Preferably, in step E of the preparation method of the plaster, the temperature of the iron pan is heated to 90-100 ℃, and sesame oil is poured into the iron pan to heat the sesame oil.
Preferably, in the step I of the preparation method of the plaster, the prepared plaster is sealed and packaged and stored for later use.
The plaster has remarkable treatment effect, and has the effects of dispelling wind and clearing heat, relaxing tendons and activating collaterals, relieving swelling and pain, promoting blood circulation by removing blood stasis and promoting new bones. Can be used for treating periostitis, osteomyelitis, bone tuberculosis, aseptic osteonecrosis, hyperosteogeny, vasculitis, sciatica, cervical spondylosis, lumbar vertebra strain, and prolapse of lumbar intervertebral disc. The plaster can also be used for treating various diseases such as traumatic injury, scapulohumeral periarthritis, rheumatic arthritis, soft tissue injury and the like. The plaster has no toxic or side effect, is convenient to use, has low production cost, and is suitable for popularization and use in patients with related diseases.
Detailed Description
The present invention will now be described in more detail, wherein preferred embodiments of the invention are shown, it being understood that one skilled in the art may modify the invention herein described while still achieving the advantageous results of the invention. Accordingly, the following description should be construed as broadly as possible to those skilled in the art and not as limiting the invention.
In the interest of clarity, not all features of an actual implementation are described. In the following description, well-known functions or constructions are not described in detail since they would obscure the invention in unnecessary detail. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific details must be set forth in order to achieve the developer's specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art.
The following description is provided to further illustrate the embodiments of the present invention, so that the objects and features of the present invention will be more clearly understood.
The plaster comprises the following components: raw kusnezoff monkshood root, raw ephedra herb, raw pinellia tuber, monkshood, raw monkshood, cortex ardisia, liquorice, cinnamon, raw south, cassia twig, pangolin scales, pseudo-ginseng, asarum, teasel root, frankincense, myrrh, sesame oil, dragon's blood, patchouli, salvia miltiorrhiza, folium artemisiae argyi, asarum, hippocampus, musk and sulfur;
the plaster comprises the following components in percentage by weight: 5-20 parts of raw kusnezoff monkshood root, 10-30 parts of raw ephedra herb, 8-25 parts of raw pinellia tuber, 15-40 parts of monkshood, 6-18 parts of raw monkshood root, 12-36 parts of Japanese ardisia root-bark, 8-15 parts of liquorice, 20-40 parts of cinnamon, 18-26 parts of raw south China, 10-20 parts of cassia twig, 20-50 parts of climbing entada stem, 15-25 parts of pseudo-ginseng, 10-22 parts of asarum, 15-30 parts of teasel root, 25-35 parts of frankincense, 20-30 parts of myrrh, 300-500 parts of sesame oil, 15-30 parts of dragon blood, 5-20 parts of patchouli, 5-12 parts of salvia miltiorrhiza, 18-35 parts of folium artemisiae argyi, 3-8 parts of asarum, 8-22 parts of hippocampus, 6-18 parts of;
the plaster comprises the following components in percentage by weight: 10 parts of raw kusnezoff monkshood root, 11 parts of raw ephedra herb, 16 parts of raw pinellia tuber, 38 parts of prepared common monkshood daughter root, 10 parts of raw common monkshood mother root, 18 parts of Japanese ardisia root-bark, 12 parts of liquorice, 36 parts of cassia bark, 19 parts of raw south China, 14 parts of cassia twig, 37 parts of climbing entada herb, 25 parts of pseudo-ginseng, 18 parts of asarum, 22 parts of teasel root, 35 parts of frankincense, 20 parts of myrrh, 400 parts of sesame oil, 30 parts of dragon's blood, 15 parts of patchouli, 5 parts of salvia miltiorrhiza, 20 parts of folium artemisiae argyi, 8 parts of asarum;
the preparation method of the plaster comprises the following steps,
A. stirring and grinding frankincense and sulfur into powder in a reaction kettle for later use;
B. mixing herba Agastaches, Saviae Miltiorrhizae radix, folium Artemisiae Argyi, herba asari, radix Aconiti Kusnezoffii, Glycyrrhrizae radix, and Hippocampus, and grinding into powder;
C. heating the copper pot to 80-110 ℃, pouring the frankincense and the sulfur powder into the copper pot, continuously stirring until the frankincense and the sulfur powder are heated and melted into liquid, pouring the traditional Chinese medicine component powder in the step B into the copper pot, and continuously stirring until the traditional Chinese medicine component powder is uniformly melted into a whole;
D. then, the musk is put into a copper pot, the copper pot is taken out of the fire, and the musk is cooled to finish the preparation work of the fire-shooting part of the plaster;
E. heating the iron pan to 90-100 deg.C, adding oleum Sesami, and heating oleum Sesami;
F. pouring radix Aconiti Kusnezoffii, herba Ephedrae, rhizoma Pinelliae, radix Aconiti lateralis Preparata, radix Aconiti, cortex Ceratophylli, Glycyrrhrizae radix, cortex Cinnamomi, rhizoma arisaematis, ramulus Cinnamomi, caulis Endadae Phaseoloidis, Notoginseng radix, herba asari, and radix Dipsaci into heated oil pan, stirring to heat the medicine uniformly, heating to liquid, removing residues, filtering, and making into ointment;
G. f, adding frankincense, myrrh and dragon's blood into the cream oil prepared in the step F, and continuously stirring until the mixture is melted;
H. d, pouring the minium into the melted cream oil in the step G, continuously heating, continuously stirring clockwise, stopping heating when the minium emits green smoke, and cooling for later use;
I. and D, adhering the fire-shooting part prepared in the step D with the cream part prepared in the step H to complete the preparation of the plaster.
The prepared plaster is sealed and packaged, and stored for later use.
The pharmaceutical efficacy of the present invention is illustrated below:
1. the patient plum is a woman of 28 years old, and before taking the medicine, the cervical vertebra is aching and painful, the head is faint, the shoulder and the back are painful, the arm is painful and powerless, the hand movement is obstructed, the arm is lifted and limited, the joint movement function is influenced, the person can not lift the spirit, and the life is difficult to take. After the plaster is used for three courses of treatment, compared with the prior symptoms, the head is not dim, the eyes are brighter, the pain of cervical vertebra, arms, shoulders and back disappears, the movement is more free, and the symptoms are treated.
2. The patient has history of a certain disease, female, age 60, knee joint pain, swelling, hydrarthrosis inside joints and other diseases before medication, difficulty in walking and weakness of feet. After two courses of treatment with the plaster, compared with the prior symptoms, the knee joint swelling disappears, the soreness and pain feeling is not existed, the walking is convenient and free, and the symptoms are treated.
3. The patient is in a certain soup, male, age 56, and has soreness of waist and pain before administration, and nerve root compression, which causes sciatica, soreness and distending pain of thigh, numbness of leg and foot, difficulty in getting up, difficulty in walking, and weakness after standing for a long time. After two courses of treatment with the plaster, compared with the previous symptoms, the pain in the waist disappears, the walking is easy and free, the legs and feet are not numb any more, and the symptoms are treated.
The plaster has remarkable treatment effect, and has the effects of dispelling wind and clearing heat, relaxing tendons and activating collaterals, relieving swelling and pain, promoting blood circulation by removing blood stasis and promoting new bones. Can be used for treating periostitis, osteomyelitis, bone tuberculosis, aseptic osteonecrosis, hyperosteogeny, vasculitis, sciatica, cervical spondylosis, lumbar vertebra strain, and prolapse of lumbar intervertebral disc. The plaster can also be used for treating various diseases such as traumatic injury, scapulohumeral periarthritis, rheumatic arthritis, soft tissue injury and the like. The plaster has no toxic or side effect, is convenient to use, has low production cost, and is suitable for popularization and use in patients with related diseases.
Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the embodiments. Thus, the present embodiments are not intended to be limited to the embodiments shown herein but are to be accorded the widest scope consistent with the principles and novel features disclosed herein.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention, and any modifications, equivalents, improvements and the like made within the spirit and principle of the present invention shall be included in the scope of the present invention.
Claims (6)
1. A musk aconite pain-relieving plaster is characterized in that the components of the plaster comprise: raw kusnezoff monkshood root, raw ephedra herb, raw pinellia tuber, monkshood, raw monkshood, cortex ardisia, liquorice, cinnamon, raw south, cassia twig, pangolin scales, pseudo-ginseng, asarum, teasel root, frankincense, myrrh, sesame oil, dragon's blood, patchouli, salvia miltiorrhiza, folium artemisiae argyi, asarum, hippocampus, musk and sulfur;
the plaster comprises the following components in percentage by weight: 5-20 parts of raw kusnezoff monkshood root, 10-30 parts of raw ephedra herb, 8-25 parts of raw pinellia tuber, 15-40 parts of monkshood, 6-18 parts of raw monkshood root, 12-36 parts of Japanese ardisia root-bark, 8-15 parts of liquorice, 20-40 parts of cinnamon, 18-26 parts of raw south China, 10-20 parts of cassia twig, 20-50 parts of climbing entada stem, 15-25 parts of pseudo-ginseng, 10-22 parts of asarum, 15-30 parts of teasel root, 25-35 parts of frankincense, 20-30 parts of myrrh, 300-500 parts of sesame oil, 15-30 parts of dragon blood, 5-20 parts of patchouli, 5-12 parts of salvia miltiorrhiza, 18-35 parts of folium artemisiae argyi, 3-8 parts of asarum, 8-22 parts of hippocampus, 6-18 parts of;
the plaster comprises the following components in percentage by weight: 10 parts of raw kusnezoff monkshood root, 11 parts of raw ephedra herb, 16 parts of raw pinellia tuber, 38 parts of prepared common monkshood daughter root, 10 parts of raw common monkshood mother root, 18 parts of Japanese ardisia root-bark, 12 parts of liquorice, 36 parts of cassia bark, 19 parts of raw south China, 14 parts of cassia twig, 37 parts of climbing entada herb, 25 parts of pseudo-ginseng, 18 parts of asarum, 22 parts of teasel root, 35 parts of frankincense, 20 parts of myrrh, 400 parts of sesame oil, 30 parts of dragon's blood, 15 parts of patchouli, 5 parts of salvia miltiorrhiza, 20 parts of folium artemisiae argyi, 8 parts of asarum;
the preparation method of the plaster comprises the following steps,
A. stirring and grinding frankincense and sulfur into powder in a reaction kettle for later use;
B. mixing herba Agastaches, Saviae Miltiorrhizae radix, folium Artemisiae Argyi, herba asari, radix Aconiti Kusnezoffii, Glycyrrhrizae radix, and Hippocampus, and grinding into powder;
C. heating the copper pot, pouring the frankincense and sulfur powder into the copper pot, continuously stirring, pouring the traditional Chinese medicine component powder in the step B into the copper pot after the frankincense powder and the sulfur powder are heated and melted into liquid, and continuously stirring to uniformly melt the traditional Chinese medicine component powder into a whole;
D. then, the musk is put into a copper pot, the copper pot is taken out of the fire, and the musk is cooled to finish the preparation work of the fire-shooting part of the plaster;
E. heating an iron pan, and pouring sesame oil into the iron pan to heat the sesame oil;
F. pouring radix Aconiti Kusnezoffii, herba Ephedrae, rhizoma Pinelliae, radix Aconiti lateralis Preparata, radix Aconiti, cortex Ceratophylli, Glycyrrhrizae radix, cortex Cinnamomi, rhizoma arisaematis, ramulus Cinnamomi, caulis Endadae Phaseoloidis, Notoginseng radix, herba asari, and radix Dipsaci into heated oil pan, stirring to heat the medicine uniformly, heating to liquid, removing residues, filtering, and making into ointment;
G. f, adding frankincense, myrrh and dragon's blood into the cream oil prepared in the step F, and continuously stirring until the mixture is melted;
H. d, pouring the minium into the melted cream oil in the step G, continuously heating, continuously stirring clockwise, stopping heating when the minium emits green smoke, and cooling for later use;
I. and D, adhering the fire-shooting part prepared in the step D with the cream part prepared in the step H to complete the preparation of the plaster.
2. The musk monkshood analgesic plaster as claimed in claim 1, wherein the plaster comprises the following components in parts by weight: 16 parts of raw kusnezoff monkshood root, 19 parts of raw ephedra, 19 parts of raw pinellia tuber, 35 parts of prepared common monkshood daughter root, 11 parts of raw common monkshood mother root, 28 parts of Japanese ardisia root-bark, 15 parts of liquorice, 40 parts of cassia bark, 20 parts of raw south China, 17 parts of cassia twig, 45 parts of climbing entada herb, 19 parts of pseudo-ginseng, 22 parts of asarum, 28 parts of teasel root, 30 parts of frankincense, 25 parts of myrrh, 409 parts of sesame oil, 17 parts of dragon's blood, 9 parts of patchouli, 11 parts of salvia miltiorrhiza, 30 parts of argy wormwood leaf, 7 parts of asarum, 21.
3. The musk monkshood analgesic plaster as claimed in claim 1, wherein the plaster comprises the following components in parts by weight: 5 parts of raw kusnezoff monkshood root, 21 parts of raw ephedra herb, 24 parts of raw pinellia tuber, 37 parts of prepared common monkshood daughter root, 10 parts of raw common monkshood mother root, 27 parts of Japanese ardisia root-bark, 14 parts of liquorice, 34 parts of cassia bark, 19 parts of raw south China, 13 parts of cassia twig, 41 parts of climbing entada herb, 20 parts of pseudo-ginseng, 22 parts of asarum, 26 parts of teasel root, 31 parts of frankincense, 24 parts of myrrh, 450 parts of sesame oil, 19 parts of dragon's blood, 16 parts of patchouli, 11 parts of salvia miltiorrhiza, 30 parts of folium artemisiae argyi, 8 parts of asarum.
4. The musk aconite pain-relieving plaster as claimed in claim 1, wherein in the step C of the preparation method of the plaster, the temperature of a copper pot is heated to 80-110 ℃, and then the frankincense and sulfur powder are poured into the copper pot and continuously stirred.
5. The musk monkshood analgesic plaster as claimed in claim 1, wherein in the preparation method step E of the plaster, the temperature of an iron pan is heated to 90-100 ℃, and sesame oil is poured into the iron pan to heat the sesame oil.
6. The musk aconite pain relieving plaster according to claim 1, wherein in the preparation method of the plaster, step I, the prepared plaster is sealed and packaged, and stored for later use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811567942.2A CN111419961A (en) | 2018-12-21 | 2018-12-21 | Pain-relieving plaster containing musk and monkshood |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811567942.2A CN111419961A (en) | 2018-12-21 | 2018-12-21 | Pain-relieving plaster containing musk and monkshood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111419961A true CN111419961A (en) | 2020-07-17 |
Family
ID=71545563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811567942.2A Pending CN111419961A (en) | 2018-12-21 | 2018-12-21 | Pain-relieving plaster containing musk and monkshood |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111419961A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257970A (en) * | 2014-10-16 | 2015-01-07 | 方斌 | Traumatic injury ointment for external use |
-
2018
- 2018-12-21 CN CN201811567942.2A patent/CN111419961A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257970A (en) * | 2014-10-16 | 2015-01-07 | 方斌 | Traumatic injury ointment for external use |
Non-Patent Citations (1)
| Title |
|---|
| 熊毛武等: "中西医结合治疗腰椎间盘炎38例", 《湖南中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101288728B (en) | Plaster for treating rheumatism, rheumatoid, a variety of hyperosteogenys | |
| CN101317996B (en) | Traditional Chinese medicine emplastrum for rheumatism of muscles and bones | |
| CN101244252A (en) | Chinese medicine label for eliminating ache and preparation thereof | |
| CN101804190B (en) | Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof | |
| CN101194990B (en) | Chinese medicine ointment for treating ache of neck, shoulder, waist and leg | |
| CN103071016B (en) | Traditional Chinese ointment for external use for curing osteoarthrosis and soft tissue injury of osteoarthrosis | |
| CN103055278A (en) | Medicament for treating rheumatism | |
| CN102366603A (en) | Medicine for treating rheumatism, rheumatoid arthritis, pain in neck, shoulder, waist and lower extremities and preparation method thereof | |
| CN103169822B (en) | Synovitis hui-nationality ointment and preparation method thereof | |
| CN102793861A (en) | Chinese medicinal plaster for treating pain in neck, shoulders, waist and legs | |
| CN102145101A (en) | Novel traditional Chinese medicine for treating rheumatic lumbocrural pains | |
| CN101313999A (en) | Pellet composition for promoting the reunion of fractured bones | |
| CN101164604A (en) | Traditional Chinese medicine for treating arthrosis and preparing method thereof | |
| CN102813867B (en) | Traditional Chinese medicinal plaster treating rheumatic arthritis | |
| CN104225534A (en) | Ointment for treating waist, shoulder and foot rheumatism and preparation method of ointment | |
| CN111419961A (en) | Pain-relieving plaster containing musk and monkshood | |
| CN104887886A (en) | Traumatic injury and fracture healing ointment | |
| CN101422531B (en) | Wind-expelling pain-assuaging paste capable of treating lumbar intervertebral disc protrusion | |
| CN101543582B (en) | Chinese medicinal ointment for treating osteopathy | |
| CN102846738A (en) | Paste for rheumatism, traumatic injury and ostealgia | |
| CN103191271A (en) | Preparation method of pain-alleviating and inflammation-diminishing ointment | |
| CN108186983B (en) | Plaster for treating rheumatoid bone diseases and preparation method thereof | |
| CN101874884A (en) | Joint pain-relieving plaster | |
| CN103212011B (en) | Bone-strengthening pain-relieving paste and preparation method thereof | |
| CN103989968A (en) | Oral traditional Chinese medicinal composition for treating cervical spinal stenosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200717 |